Incidence of mandibular osteoradionecrosis may be low in head and neck cancer patients treated with concurrent radiation and weekly paclitaxel.
Mumyakmaz
Kadir
K
Mumyakmaz
Fatma
F
Altundag
Kadri
K
Altundag
Ozden
O
D000970:Antineoplastic Agents / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D015897:Comorbidity; D006258:Head and Neck Neoplasms / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D015994:Incidence; D008336:Mandibular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D010025:Osteoradionecrosis / Q000453:epidemiology* / Q000517:prevention & control*; D017239:Paclitaxel / Q000008:administration & dosage*; D011835:Radiation Protection / Q000379:methods; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors
D000970:Antineoplastic Agents; D017239:Paclitaxel